Relationship between unexplained elevations in alanine aminotransferase and serum leptin in U.S. adults: Results from the Third National Health and Nutrition Examination Survey (NHANES III)

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Introduction: There has been an interest to explore whether serum leptin plays any role in the pathogenesis of chronic liver disease. We conducted a case-control study to evaluate the relationship between unexplained elevations in ALT and serum leptin in NHANES III participants. Methods: A total of 6343 adults who had fasting serum leptin and ALT measured as part of NHANES III constituted our study group. From this database, we have constructed cohorts of patients with unexplained elevations in ALT according to published criteria and compared their serum leptin levels to matched controls without liver disease and matched controls with hepatitis C. Leptin was also compared between patients with unexplained elevations in ALT with and without metabolic syndrome. Results: Serum leptin in 288 patients with unexplained elevations in ALT was 13.3 ± 9.9 ng/mL and was not significantly different than 720 controls without liver disease (13.6 ± 11.9 ng/mL, P = 0.6). Serum leptin in another group of patients with unexplained elevations in ALT and hepatitis C controls was also not significantly different (8.0 ± 4.8 vs. 8.8 ± 7.4 ng/mL, respectively, P = 0.5). There was no independent relationship between the presence of metabolic syndrome and serum leptin in individuals with unexplained elevations in ALT (P = 0.8). Conclusions: Individuals with unexplained elevations in ALT did not have higher levels of serum leptin than the matched controls. As unexplained elevations in ALT may signify the presence of non-alcoholic fatty liver disease in NHANES III participants, our data provide indirect evidence against a role for serum leptin in the pathogenesis of nonalcoholic fatty liver disease.

Original languageEnglish
Pages (from-to)891-897
Number of pages7
JournalJournal of Clinical Gastroenterology
Volume38
Issue number10
DOIs
StatePublished - Nov 2004

Fingerprint

Nutrition Surveys
Leptin
Alanine Transaminase
Serum
Liver Diseases
Hepatitis C
Case-Control Studies
Fasting
Chronic Disease
Databases

Keywords

  • NHANES III
  • Nonalcoholic fatty liver disease
  • Serum leptin

ASJC Scopus subject areas

  • Gastroenterology

Cite this

@article{daa8676d8f184288a520b14686207838,
title = "Relationship between unexplained elevations in alanine aminotransferase and serum leptin in U.S. adults: Results from the Third National Health and Nutrition Examination Survey (NHANES III)",
abstract = "Introduction: There has been an interest to explore whether serum leptin plays any role in the pathogenesis of chronic liver disease. We conducted a case-control study to evaluate the relationship between unexplained elevations in ALT and serum leptin in NHANES III participants. Methods: A total of 6343 adults who had fasting serum leptin and ALT measured as part of NHANES III constituted our study group. From this database, we have constructed cohorts of patients with unexplained elevations in ALT according to published criteria and compared their serum leptin levels to matched controls without liver disease and matched controls with hepatitis C. Leptin was also compared between patients with unexplained elevations in ALT with and without metabolic syndrome. Results: Serum leptin in 288 patients with unexplained elevations in ALT was 13.3 ± 9.9 ng/mL and was not significantly different than 720 controls without liver disease (13.6 ± 11.9 ng/mL, P = 0.6). Serum leptin in another group of patients with unexplained elevations in ALT and hepatitis C controls was also not significantly different (8.0 ± 4.8 vs. 8.8 ± 7.4 ng/mL, respectively, P = 0.5). There was no independent relationship between the presence of metabolic syndrome and serum leptin in individuals with unexplained elevations in ALT (P = 0.8). Conclusions: Individuals with unexplained elevations in ALT did not have higher levels of serum leptin than the matched controls. As unexplained elevations in ALT may signify the presence of non-alcoholic fatty liver disease in NHANES III participants, our data provide indirect evidence against a role for serum leptin in the pathogenesis of nonalcoholic fatty liver disease.",
keywords = "NHANES III, Nonalcoholic fatty liver disease, Serum leptin",
author = "Suthat Liangpunsakul and Naga Chalasani",
year = "2004",
month = "11",
doi = "10.1097/00004836-200411000-00012",
language = "English",
volume = "38",
pages = "891--897",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Relationship between unexplained elevations in alanine aminotransferase and serum leptin in U.S. adults

T2 - Results from the Third National Health and Nutrition Examination Survey (NHANES III)

AU - Liangpunsakul, Suthat

AU - Chalasani, Naga

PY - 2004/11

Y1 - 2004/11

N2 - Introduction: There has been an interest to explore whether serum leptin plays any role in the pathogenesis of chronic liver disease. We conducted a case-control study to evaluate the relationship between unexplained elevations in ALT and serum leptin in NHANES III participants. Methods: A total of 6343 adults who had fasting serum leptin and ALT measured as part of NHANES III constituted our study group. From this database, we have constructed cohorts of patients with unexplained elevations in ALT according to published criteria and compared their serum leptin levels to matched controls without liver disease and matched controls with hepatitis C. Leptin was also compared between patients with unexplained elevations in ALT with and without metabolic syndrome. Results: Serum leptin in 288 patients with unexplained elevations in ALT was 13.3 ± 9.9 ng/mL and was not significantly different than 720 controls without liver disease (13.6 ± 11.9 ng/mL, P = 0.6). Serum leptin in another group of patients with unexplained elevations in ALT and hepatitis C controls was also not significantly different (8.0 ± 4.8 vs. 8.8 ± 7.4 ng/mL, respectively, P = 0.5). There was no independent relationship between the presence of metabolic syndrome and serum leptin in individuals with unexplained elevations in ALT (P = 0.8). Conclusions: Individuals with unexplained elevations in ALT did not have higher levels of serum leptin than the matched controls. As unexplained elevations in ALT may signify the presence of non-alcoholic fatty liver disease in NHANES III participants, our data provide indirect evidence against a role for serum leptin in the pathogenesis of nonalcoholic fatty liver disease.

AB - Introduction: There has been an interest to explore whether serum leptin plays any role in the pathogenesis of chronic liver disease. We conducted a case-control study to evaluate the relationship between unexplained elevations in ALT and serum leptin in NHANES III participants. Methods: A total of 6343 adults who had fasting serum leptin and ALT measured as part of NHANES III constituted our study group. From this database, we have constructed cohorts of patients with unexplained elevations in ALT according to published criteria and compared their serum leptin levels to matched controls without liver disease and matched controls with hepatitis C. Leptin was also compared between patients with unexplained elevations in ALT with and without metabolic syndrome. Results: Serum leptin in 288 patients with unexplained elevations in ALT was 13.3 ± 9.9 ng/mL and was not significantly different than 720 controls without liver disease (13.6 ± 11.9 ng/mL, P = 0.6). Serum leptin in another group of patients with unexplained elevations in ALT and hepatitis C controls was also not significantly different (8.0 ± 4.8 vs. 8.8 ± 7.4 ng/mL, respectively, P = 0.5). There was no independent relationship between the presence of metabolic syndrome and serum leptin in individuals with unexplained elevations in ALT (P = 0.8). Conclusions: Individuals with unexplained elevations in ALT did not have higher levels of serum leptin than the matched controls. As unexplained elevations in ALT may signify the presence of non-alcoholic fatty liver disease in NHANES III participants, our data provide indirect evidence against a role for serum leptin in the pathogenesis of nonalcoholic fatty liver disease.

KW - NHANES III

KW - Nonalcoholic fatty liver disease

KW - Serum leptin

UR - http://www.scopus.com/inward/record.url?scp=6944221345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=6944221345&partnerID=8YFLogxK

U2 - 10.1097/00004836-200411000-00012

DO - 10.1097/00004836-200411000-00012

M3 - Article

C2 - 15492608

AN - SCOPUS:6944221345

VL - 38

SP - 891

EP - 897

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 10

ER -